Schonfeld Strategic Advisors’s Compugen CGEN Stock Holding History
Bought
Maintained
Sold
Other funds holding CGEN
DKCM
TFCM
RSCM
AIM
Schonfeld Strategic Advisors's CGEN Position: Q3 2022 in Review
Schonfeld Strategic Advisors sold out of Compugen (CGEN) in Q3 2022, closing a stake of 138,680 shares — an estimated $257K sold.
Schonfeld Strategic Advisors first reported a position in CGEN in Q2 2022 and held it in 1 quarter. The position peaked at $257K in Q2 2022. 81 funds tracked by Wall St. Rank hold CGEN as of Q3 2022.
- Schonfeld Strategic Advisors reported no remaining Compugen position as of Q3 2022 after selling out during the quarter.
- Schonfeld Strategic Advisors sold 138,680 Compugen shares in Q3 2022, an estimated $257K.
- Schonfeld Strategic Advisors first reported a position in Compugen in Q2 2022 and held it in 1 quarter.
- Schonfeld Strategic Advisors's Compugen position peaked at $257K in Q2 2022.
- 81 funds tracked by Wall St. Rank held Compugen as of Q3 2022.
Based on Schonfeld Strategic Advisors's 13F filing for Q3 2022, filed 14 Nov 2022.